Cost effectiveness analysis with externalities the case of std and aids prevention in developing countries
Over, M.; Piot, P.
Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress Amsterdam, Netherlands Paper : d454
1992
Document Number: 322751
Document emailed within 1 workday
Related Documents
Walker, D. 2003: Cost and cost-effectiveness of HIV/AIDS prevention strategies in developing countries: is there an evidence base? Health Policy and Planning 18(1): 4-17Hogan, D.R.; Baltussen, R.; Hayashi, C.; Lauer, J.A.; Salomon, J.A. 2005: Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries Bmj 331(7530): 1431-1437
Valencia-Mendoza, A.; Bertozzi, S.M.; Gutierrez, J.-P.; Itzler, R. 2008: Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico Bmc Infectious Diseases 8: 103
Newell, M.L.; Dabis, F.; Tolley, K.; Whynes, D. 1998: Cost-effectiveness and cost-benefit in the prevention of mother-to-child transmission of HIV in developing countries. Ghent International Working Group on Mother-to-Child Transmission of HIV Aids 12(13): 1571-1580
Medley, A.; Kennedy, C.; O'Reilly, K.; Sweat, M. 2009: Effectiveness of peer education interventions for HIV prevention in developing countries: a systematic review and meta-analysis Aids Education and Prevention: Official Publication of the International Society for Aids Education 21(3): 181-206
Adam, T.; Lim, S., S.; Mehta, S.; Bhutta, Z., A.; Fogstad, H.; Mathai, M.; Zupan, J.; Darmstadt, G., L. 2005: Achieving the millennium development goals for health - Cost effectiveness analysis of strategies for. maternal and neonatal health in developing countries BMJ 331(7525): 1107-1110
Henley, C.; Forgwei, G.; Welty, T.; Golden, M.; Adimora, A.; Shields, R.; Muffih, P.Tih. 2013: Scale-up and case-finding effectiveness of an HIV partner services program in Cameroon: an innovative HIV prevention intervention for developing countries Sexually Transmitted Diseases 40(12): 909-914
Lee, R.D.; Miller, T. 1990: Population growth, externalities to childbearing, and fertility policy in developing countries Proceedings of the World Bank Annual Conference of Development Economics 1990: 275-304
Termrungruanglert, W.; Havanond, P.; Khemapech, N.; Lertmaharit, S.; Pongpanich, S.; Khorprasert, C.; Taneepanichskul, S. 2012: Cost and effectiveness evaluation of prophylactic HPV vaccine in developing countries Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 15(1 Suppl): S29-S34
Aggarwal, R.; Ghoshal, U.C.; Naik, S.R. 2002: Treatment of chronic hepatitis B with interferon-alpha: cost-effectiveness in developing countries National Medical Journal of India 15(6): 320-327
Hutton, G.; Wyss, K.; N'Diékhor, Y. 2003: Prioritization of prevention activities to combat the spread of HIV/AIDS in resource constrained settings: a cost-effectiveness analysis from Chad, Central Africa International Journal of Health Planning and Management 18(2): 117-136
Harmon, T.M.; Fisher, K.A.; McGlynn, M.G.; Stover, J.; Warren, M.J.; Teng, Y.; Näveke, A. 2016: Exploring the Potential Health Impact and Cost-Effectiveness of AIDS Vaccine within a Comprehensive HIV/AIDS Response in Low- and Middle-Income Countries Plos one 11(1): E0146387
Bourinbaiar, A.S.; Jirathitikal, V. 2003: Low-cost anti-HIV compounds: potential application for AIDS therapy in developing countries Current Pharmaceutical Design 9(18): 1419-1431
Betegón, L.; Cotarelo, M.; Vendrell, Bén. 2012: Cost and cost-effectiveness analysis of the preferred treatment for initial antiretroviral therapy in HIV infected adults according to 2012 GESIDA/National AIDS Plan guidelines Enfermedades infecciosas y microbiologia clinica 30(8): 508-9; author reply 511-2
Mori, A.Thomas.; Kampata, L.; Musonda, P.; Johansson, K.Arne.; Robberstad, B.; Sandøy, I. 2017: Cost-benefit and extended cost-effectiveness analysis of a comprehensive adolescent pregnancy prevention program in Zambia: study protocol for a cluster randomized controlled trial Trials 18(1): 604
Temmerman, M.; Marres, D. 1995: Social and cultural obstacles to AIDS prevention in developing countries Tijdschrift Voor Sociale Wetenschappen 40(1): 24-33
Jordão, E.P.; Volschan, I. 2004: Cost-effective solutions for sewage treatment in developing countries--the case of Brazil Water Science and Technology: a Journal of the International Association on Water Pollution Research 50(7): 237-242
VanDeusen, A.; Paintsil, E.; Agyarko-Poku, T.; Long, E.F. 2015: Cost effectiveness of option B plus for prevention of mother-to-child transmission of HIV in resource-limited countries: evidence from Kumasi, Ghana Bmc Infectious Diseases 15: 130
Ferreros, C.; Mivumbi, N.; Kakera, K.; Price, J. 1990: Social marketing of condoms for aids prevention in developing countries the zaire experience Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Sc697
Gómez-Román, V.R. 2003: HIV/AIDS prevention programs in developing countries are deficient without an appropriate scientific research infrastructure Aids 17(7): 1114-1116